Drug intelligence / Profile preview

Stifen-P

Development stage
Unknown
Lead developer
Med Manor Organics
Modality
Small Molecules
Administration
Oral
01

Overview

Stifen-P is an oral fixed-dose combination tablet containing the non-steroidal anti-inflammatory drug (NSAID) aceclofenac and the analgesic/antipyretic paracetamol (acetaminophen). Developed and marketed by Med Manor Organics, it is indicated for the short-term relief of mild-to-moderate pain, inflammation, and fever. It is commonly prescribed for musculoskeletal pain, joint pain, and inflammatory conditions such as osteoarthritis, rheumatoid arthritis, and ankylosing spondylitis. Aceclofenac works by preferentially inhibiting the cyclooxygenase-2 (COX-2) enzyme, thereby blocking the synthesis of inflammatory prostaglandins. Paracetamol acts primarily on the central nervous system to inhibit prostaglandin synthesis and modulate endogenous pain pathways, raising the pain threshold and reducing fever. Together, these components provide synergistic analgesic, anti-inflammatory, and antipyretic effects.

Brand names
Stifen-P
Other names
aceclofenac + acetaminophenaceclofenac + paracetamol
02

Targets

PGHS-1 (Prostaglandin G/H Synthase 1)

Beyond the preview

Go deeper on Stifen-P.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Stifen-P.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call